Benjamin A Weinberg1, John L Marshall2. 1. Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, D.C, 20007, USA. baw12@gunet.georgetown.edu. 2. Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, D.C, 20007, USA.
Abstract
PURPOSE OF REVIEW: The recent rise of young individuals under age 50 with colorectal cancer (CRC) is a startling trend in need of greater focus and research. The etiology of young-onset CRC is unexplained as efforts to blame obesity or diabetes as causative factors are simplistic and inadequate. RECENT FINDINGS: We describe the epidemiologic shifts of CRC incidence and mortality across age groups as well as the differences in clinicopathologic, molecular, treatment, and survival characteristics between young and older patients. Novel studies of the microbiome may elucidate bacterial causes of CRC carcinogenesis in younger individuals. Moving up the colonoscopy screening to age 45 in normal-risk individuals should prove beneficial in detecting more patients with early-onset CRC. We favor the development of risk-adaptive screening decision algorithms and flexible sigmoidoscopy screening at age 40 given the predilection for left-sided primaries in this age group. More awareness and attention to young-onset CRC will be critical to improve outcomes in this patient population.
PURPOSE OF REVIEW: The recent rise of young individuals under age 50 with colorectal cancer (CRC) is a startling trend in need of greater focus and research. The etiology of young-onset CRC is unexplained as efforts to blame obesity or diabetes as causative factors are simplistic and inadequate. RECENT FINDINGS: We describe the epidemiologic shifts of CRC incidence and mortality across age groups as well as the differences in clinicopathologic, molecular, treatment, and survival characteristics between young and older patients. Novel studies of the microbiome may elucidate bacterial causes of CRC carcinogenesis in younger individuals. Moving up the colonoscopy screening to age 45 in normal-risk individuals should prove beneficial in detecting more patients with early-onset CRC. We favor the development of risk-adaptive screening decision algorithms and flexible sigmoidoscopy screening at age 40 given the predilection for left-sided primaries in this age group. More awareness and attention to young-onset CRC will be critical to improve outcomes in this patient population.
Authors: Jeong Eun Kim; Yong Sang Hong; Hwa Jung Kim; Kyu-Pyo Kim; Jae-Lyun Lee; Seong Joon Park; Seok-Byung Lim; In Ja Park; Chan Wook Kim; Yong Sik Yoon; Chang Sik Yu; Jin Cheon Kim; Kim Ji Hoon; Tae Won Kim Journal: Ann Surg Oncol Date: 2015-08-14 Impact factor: 5.344
Authors: S Y Brulé; D J Jonker; C S Karapetis; C J O'Callaghan; M J Moore; R Wong; N C Tebbutt; Cr Underhill; D Yip; J R Zalcberg; D Tu; R A Goodwin Journal: Eur J Cancer Date: 2015-05-12 Impact factor: 9.162
Authors: Susan Bullman; Chandra S Pedamallu; Ewa Sicinska; Thomas E Clancy; Xiaoyang Zhang; Diana Cai; Donna Neuberg; Katherine Huang; Fatima Guevara; Timothy Nelson; Otari Chipashvili; Timothy Hagan; Mark Walker; Aruna Ramachandran; Begoña Diosdado; Garazi Serna; Nuria Mulet; Stefania Landolfi; Santiago Ramon Y Cajal; Roberta Fasani; Andrew J Aguirre; Kimmie Ng; Elena Élez; Shuji Ogino; Josep Tabernero; Charles S Fuchs; William C Hahn; Paolo Nuciforo; Matthew Meyerson Journal: Science Date: 2017-11-23 Impact factor: 47.728
Authors: Laura Rodriguez; Kelly Brennan; Safiya Karim; Sulaiman Nanji; Sunil V Patel; Christopher M Booth Journal: Clin Colorectal Cancer Date: 2018-07-03 Impact factor: 4.481
Authors: Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz Journal: N Engl J Med Date: 2015-05-30 Impact factor: 91.245
Authors: H T Lynch; W Kimberling; W A Albano; J F Lynch; K Biscone; G S Schuelke; A A Sandberg; M Lipkin; E E Deschner; Y B Mikol Journal: Cancer Date: 1985-08-15 Impact factor: 6.860
Authors: Andrew Hendifar; Dongyun Yang; Felicitas Lenz; Georg Lurje; Alexandra Pohl; Cosima Lenz; Yan Ning; Wu Zhang; Heinz-Josef Lenz Journal: Clin Cancer Res Date: 2009-09-29 Impact factor: 12.531
Authors: Zaid M Abdelsattar; Sandra L Wong; Scott E Regenbogen; Diana M Jomaa; Karin M Hardiman; Samantha Hendren Journal: Cancer Date: 2016-01-25 Impact factor: 6.860
Authors: Alberto Puccini; Heinz-Josef Lenz; John L Marshall; David Arguello; Derek Raghavan; W Michael Korn; Benjamin A Weinberg; Kelsey Poorman; Arielle L Heeke; Philip A Philip; Anthony F Shields; Richard M Goldberg; Mohamed E Salem Journal: Oncologist Date: 2018-07-17
Authors: Eric E Low; Joshua Demb; Lin Liu; Ashley Earles; Ranier Bustamante; Christina D Williams; Dawn Provenzale; Tonya Kaltenbach; Andrew J Gawron; Maria Elena Martinez; Samir Gupta Journal: Gastroenterology Date: 2020-01-09 Impact factor: 22.682
Authors: Claire L Bensard; Dona R Wisidagama; Kristofor A Olson; Jordan A Berg; Nathan M Krah; John C Schell; Sara M Nowinski; Sarah Fogarty; Alex J Bott; Peng Wei; Katja K Dove; Jason M Tanner; Vanja Panic; Ahmad Cluntun; Sandra Lettlova; Christian S Earl; David F Namnath; Karina Vázquez-Arreguín; Claudio J Villanueva; Dean Tantin; L Charles Murtaugh; Kimberley J Evason; Gregory S Ducker; Carl S Thummel; Jared Rutter Journal: Cell Metab Date: 2019-12-05 Impact factor: 27.287